Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03871075 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease

Study acronym: INTERCEDE
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 4 more changesShow less
    • Study completion date changed from estimate of Apr 2027 to Sep 17, 2026
    • Primary completion date changed from estimate of Sep 2026 to Aug 28, 2026
    • Eligibility criteria shortened, about 28 words
    • Publications: details revised at 1 of 1 entry
  2. Trial status: Recruiting to Active, Not Recruitingv10 Show 4 more changesShow less
    • Enrollment target: estimated 230 to confirmed 211
    • Primary completion date: Jul 2026 to Sep 2026
    • Study completion date: Nov 2026 to Apr 2027
    • Site details revised at 4 of 4 sites
  3. Re-verified, no change to tracked fieldsv9
  4. Primary completion date: Apr 2024 to Jul 2026
    • Study completion date: Oct 2024 to Nov 2026
    v8
  5. Study sites: 2 to 4v7
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites: 1 to 2
    • Eligibility criteria expanded, about 45 words
    v6
  2. Eligibility criteria expanded, about 67 wordsv5
  3. Re-verified, no change to tracked fieldsv4
  4. Eligibility criteria expanded, about 72 wordsv3
  5. Secondary endpoints: details revised at 14 of 14 entries
    • Study description revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The INTERCEDE randomized trial will establish whether six-months of intermittent pneumatic compression combined with walking exercise improves walking endurance at six-month follow-up, compared to walking exercise + sham compression therapy, in people with lower extremity peripheral artery disease (PAD). The INTERCEDE trial will also determine whether intermittent pneumatic compression therapy improves walking endurance at 6-month follow-up, compared to a sham compression therapy. The trial will also determine whether benefits of intermittent pneumatic compression persist after intermittent pneumatic compression treatment is completed.
Trial Details
NCT Number NCT03871075
Lead Sponsor Northwestern University
Collaborators: National Institute on Aging (NIA)
Conditions
(from sponsor)		 Peripheral Artery Disease
Related terms Intermittent Claudication, Motor Activity, Peripheral Arterial Disease
Enrollment 211 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov